Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -155.59% is 61% below its 5-year average of -96.83%, near the high end of its 5-year range (-2854.65%–77.47%).
74.24% above its 12-month average of -604.00%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -42.42%.
NET PROFIT MARGIN
-155.59%
NET PROFIT MARGIN AVG TTM
-604.00%
NET PROFIT MARGIN AVG 3Y
-136.53%
NET PROFIT MARGIN AVG 5Y
-96.83%
NET PROFIT MARGIN AVG 10Y
-78.71%
NET PROFIT MARGIN AVG 15Y
-112.66%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+74.24%
CURRENT VS 3Y AVG
-13.96%
CURRENT VS 5Y AVG
-60.69%
CURRENT VS 10Y AVG
-97.68%
CURRENT VS 15Y AVG
-38.11%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-44354.29%
vs the sector median at left
Xencor, Inc.
Market Cap
$1.81B
Net Profit Margin
-155.59%
TTM Avg
-604.00%
3Y Avg
-136.53%
5Y Avg
-96.83%
Market Cap
$1.81B
Net Profit Margin
25.02%
TTM Avg
21.58%
3Y Avg
17.87%
5Y Avg
17.55%
Market Cap
$1.81B
Net Profit Margin
-20.02%
TTM Avg
-19.08%
3Y Avg
-29.38%
5Y Avg
-13.21%
Market Cap
$1.83B
Net Profit Margin
-6.93%
TTM Avg
-10.04%
3Y Avg
-34.65%
5Y Avg
-50.14%
Market Cap
$1.83B
Net Profit Margin
1.05%
TTM Avg
1.42%
3Y Avg
2.79%
5Y Avg
2.28%
Market Cap
$1.84B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-32.12%
5Y Avg
-45.68%
Market Cap
$1.77B
Net Profit Margin
-636.99%
TTM Avg
-743.17%
3Y Avg
-743.17%
5Y Avg
-743.17%
Market Cap
$1.85B
Net Profit Margin
-3059.99%
TTM Avg
-3150.18%
3Y Avg
-1765.57%
5Y Avg
-1177.05%
Market Cap
$1.75B
Net Profit Margin
-2.63%
TTM Avg
-3.88%
3Y Avg
-2.58%
5Y Avg
-3.29%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xencor, Inc. (XNCR) | $1.81B | -155.59% | -604.00% | -136.53% | -96.83% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 25.02% | 21.58% | 17.87% | 17.55% |
| Azenta, Inc. (AZTA)vs › | $1.81B | -20.02% | -19.08% | -29.38% | -13.21% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | -6.93% | -10.04% | -34.65% | -50.14% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.05% | 1.42% | 2.79% | 2.28% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | 0.00% | 0.00% | -32.12% | -45.68% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | -636.99% | -743.17% | -743.17% | -743.17% |
| Immunome, Inc. (IMNM)vs › | $1.85B | -3059.99% | -3150.18% | -1765.57% | -1177.05% |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | -2.63% | -3.88% | -2.58% | -3.29% |
| Novavax, Inc. (NVAX)vs › | $1.86B | -59.87% | 5.85% | -31.86% | -479.70% |
Operating Margin
-141.3%
Net Profit Margin
-155.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -42.42% |
| 2026-03-31 | -2854.65% |
| 2025-12-31 | -23.56% |
| 2025-09-30 | -28.70% |
| 2025-06-30 | -70.69% |
| 2025-03-31 | -147.92% |
| 2024-12-31 | -76.38% |
| 2024-09-30 | -260.10% |
| 2024-06-30 | -388.93% |
| 2024-03-31 | -459.09% |
| 2023-12-31 | -51.30% |
| 2023-09-30 | -41.02% |
| 2023-06-30 | -48.23% |
| 2023-03-31 | -320.45% |
| 2022-12-31 | -55.72% |
| 2022-09-30 | -120.00% |
| 2022-06-30 | -112.59% |
| 2022-03-31 | 27.60% |
| 2021-12-31 | 47.44% |
| 2021-09-30 | -204.19% |
| 2021-06-30 | 77.47% |
| 2021-03-31 | -7.32% |
| 2020-12-31 | -32.71% |
| 2020-09-30 | -35.49% |
| 2020-06-30 | -267.54% |
| 2020-03-31 | -24.93% |
| 2019-12-31 | -765.42% |
| 2019-09-30 | -46.99% |
| 2019-06-30 | -82.29% |
| 2019-03-31 | 71.51% |
| 2018-12-31 | -157.38% |
| 2018-09-30 | 10.85% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | -108.24% |
| 2017-09-30 | -219.49% |
| 2017-06-30 | -51.61% |
| 2017-03-31 | -337.21% |
| 2016-12-31 | -140.76% |
| 2016-09-30 | -103.27% |
| 2016-06-30 | 71.45% |
| 2016-03-31 | -88.22% |
| 2015-12-31 | 35.66% |
| 2015-09-30 | -286.53% |
| 2015-06-30 | -874.56% |
| 2015-03-31 | -432.19% |
| 2014-12-31 | -23.83% |
| 2014-09-30 | -740.33% |
| 2014-06-30 | -612.14% |
| 2014-03-31 | -171.75% |
| 2013-12-31 | -212.27% |
| 2013-09-30 | -58.03% |
| 2013-06-30 | -1277.96% |
| 2013-03-31 | -342.90% |
| 2012-12-31 | -128.29% |
| 2012-09-30 | -164.28% |
